DSM presents nutritional ingredients for risk reduction in cardiovascular disease at ESC Congress
DSM, stand C720, ESC Congress, London, 29 August – 2 September 2015
DSM is to chair a scientific symposium at the European Society of Cardiology (ESC) Congress, as it raises awareness of the importance of good nutrition as part of a practical risk reduction approach to cardiovascular health concerns. DSM is a leader in the field of micronutrients, and its portfolio of safe and scientifically substantiated ingredients for heart health can support a primary prevention strategy through regular intake.
The nutritional solutions are backed by science and include:
- Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) beneficially modify blood pressure and triglyceride levels1. Scientific evidence from a number of human studies also demonstrates that polyunsaturated fatty acids in membranes reduce platelet aggregation and lower expression of genes that promote inflammation. Inflammation is the initiator of most types of cardiovascular disease2.
- DSM’s Fruitflow®, a water soluble tomato extract, has been shown to inhibit platelet aggregation and improve blood flow in up to 97 per cent of individuals within 1.5 hours of consumption3.
- Lowering cholesterol to reduce cardiovascular risk is an accepted lifestyle modification recommended by European guidelines4. A soluble dietary fiber, oat beta-glucan is the active component of oats. The consumption of at least 3 g/day of oat beta-glucan can achieve a reduction in LDL cholesterol of up to 10%5.
The European Commission has approved several health claims in relation to cardiovascular health6.
“Despite it being common knowledge that certain dietary habits are protective against cardiovascular disease, almost half of UK adults still struggle to eat a nutritionally balanced diet7" comments Dr. Manfred Eggersdorfer, Professor for Healthy Ageing at Groningen University and a senior scientist at DSM. “In the UK today, only 7% of adults aged 35 aged and over cite heart health as their main health concern. More needs to be done to educate both the medical community and patients on the efficacy of safe, natural nutritional solutions, as an alternative to or in conjunction with pharmaceutical methods of primary and secondary prevention.”
The satellite symposium – ‘Nutritional ingredients for risk reduction in cardiovascular disease’ – is to be held from 13:00 to 13:45 on Monday 31 August in Stockholm Village One. Two leading scientists will share the latest clinical data in specialist fields of progressive research. Dr. Philip C Calder, Professor of Nutritional Immunology at the University of Southampton will discuss the role of marine fatty acids in primary and secondary risk reduction. Dr. Niamh O’Kennedy, Honorary Research Fellow at the University of Aberdeen will then present the potential of lycopene-free tomato extracts in primary prevention.
Visitors to the ESC Congress can learn more about the types of products that feature DSM’s heart health ingredients at stand C720, where samples and prototypes on display include OatWell® powders and sachets that are available at selected retail outlets in the UK.
To find out more on the latest research, visit www.vitaminsinmotion.com and download a copy of DSM’s infographic – ‘Nutritional solutions for heart health’. DSM has also partnered with a number of leading scientific experts to launch a series of webinars on new science on micronutrients and human health. To access the presentations, please visit www.brighttalk.com/channel/12499.
1 Mozaffarian D., Jason P.H. and Wu H.Y., ‘Omega-3 Fatty Acids and Cardiovascular Disease: Effects on Risk Factors, Molecular Pathways and Clinical Events’ J Am Coll Cardiol, 2011: 58(20):247-67
2 Calder P.C., ‘Very long chain omega-3(n-3) fatty acids and human health’ Eur J Lipid Sci Technol 2014, 116: 1280-1300
3 ’Kennedy N. et al, ‘Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans’, Am J Clin Nutr. 2006 Sep;84(3):561-9
4 The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2011;32:1769–818.
7 UK heart health and nutrition survey, commissioned by DSM and carried out independently by Edelman Berland.